Literature DB >> 26822036

Nuclear Mechanisms of Insulin Resistance.

Sona Kang1, Linus T-Y Tsai2, Evan D Rosen3.   

Abstract

Insulin resistance is a sine qua non of type 2 diabetes and is associated with many other clinical conditions. Decades of research into mechanisms underlying insulin resistance have mostly focused on problems in insulin signal transduction and other mitochondrial and cytosolic pathways. By contrast, relatively little attention has been focused on transcriptional and epigenetic contributors to insulin resistance, despite strong evidence that such nuclear mechanisms play a major role in the etiopathogenesis of this condition. In this review, we summarize the evidence for nuclear mechanisms of insulin resistance, focusing on three transcription factors with a major impact on insulin action in liver, muscle, and fat.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26822036      PMCID: PMC4844850          DOI: 10.1016/j.tcb.2016.01.002

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  99 in total

1.  Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity.

Authors:  Shamina M Rangwala; Ben Rhoades; Jennifer S Shapiro; A Sophie Rich; Jason K Kim; Gerald I Shulman; Klaus H Kaestner; Mitchell A Lazar
Journal:  Dev Cell       Date:  2003-10       Impact factor: 12.270

Review 2.  Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator.

Authors:  Pere Puigserver; Bruce M Spiegelman
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

3.  Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis.

Authors:  Evan D Rosen; Rohit N Kulkarni; Pasha Sarraf; Umut Ozcan; Terumasa Okada; Chung-Hsin Hsu; Daniel Eisenman; Mark A Magnuson; Frank J Gonzalez; C Ronald Kahn; Bruce M Spiegelman
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

4.  Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.

Authors:  Weimin He; Yaacov Barak; Andrea Hevener; Peter Olson; Debbie Liao; Jamie Le; Michael Nelson; Estelita Ong; Jerrold M Olefsky; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

5.  Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis.

Authors:  Katsumi Iizuka; Richard K Bruick; Guosheng Liang; Jay D Horton; Kosaku Uyeda
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

6.  Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin.

Authors:  J-M Ye; N Dzamko; M E Cleasby; B D Hegarty; S M Furler; G J Cooney; E W Kraegen
Journal:  Diabetologia       Date:  2004-07-01       Impact factor: 10.122

7.  Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.

Authors:  Pere Puigserver; James Rhee; Jerry Donovan; Christopher J Walkey; J Cliff Yoon; Francesco Oriente; Yukari Kitamura; Jennifer Altomonte; Hengjiang Dong; Domenico Accili; Bruce M Spiegelman
Journal:  Nature       Date:  2003-05-18       Impact factor: 49.962

8.  Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.

Authors:  Andrew W Norris; Lihong Chen; Simon J Fisher; Ildiko Szanto; Michael Ristow; Alison C Jozsi; Michael F Hirshman; Evan D Rosen; Laurie J Goodyear; Frank J Gonzalez; Bruce M Spiegelman; C Ronald Kahn
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

9.  Muscle-specific Pparg deletion causes insulin resistance.

Authors:  Andrea L Hevener; Weimin He; Yaacov Barak; Jamie Le; Gautam Bandyopadhyay; Peter Olson; Jason Wilkes; Ronald M Evans; Jerrold Olefsky
Journal:  Nat Med       Date:  2003-11-16       Impact factor: 53.440

10.  Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus.

Authors:  Christian Opherk; François Tronche; Christoph Kellendonk; Dirk Kohlmüller; Andreas Schulze; Wolfgang Schmid; Günther Schütz
Journal:  Mol Endocrinol       Date:  2004-03-18
View more
  24 in total

1.  Non-monotonic dose-response effects of arsenic on glucose metabolism.

Authors:  Yingyun Gong; Jidong Liu; Yanfeng Xue; Zhong Zhuang; Sichong Qian; Wenjun Zhou; Xin Li; Justin Qian; Guolian Ding; Zheng Sun
Journal:  Toxicol Appl Pharmacol       Date:  2019-06-03       Impact factor: 4.219

2.  Oral Corticosterone Administration Reduces Insulitis but Promotes Insulin Resistance and Hyperglycemia in Male Nonobese Diabetic Mice.

Authors:  Susan J Burke; Heidi M Batdorf; Adrianna E Eder; Michael D Karlstad; David H Burk; Robert C Noland; Z Elizabeth Floyd; J Jason Collier
Journal:  Am J Pathol       Date:  2017-01-04       Impact factor: 4.307

Review 3.  Insulin action and resistance in obesity and type 2 diabetes.

Authors:  Michael P Czech
Journal:  Nat Med       Date:  2017-07-11       Impact factor: 53.440

Review 4.  Pioglitazone and cardiovascular risk reduction: time for a second look?

Authors:  Ana L Perdigoto; Lawrence H Young; Silvio E Inzucchi
Journal:  Cardiovasc Endocrinol       Date:  2017-05-17

5.  Thymol improves high-fat diet-induced cognitive deficits in mice via ameliorating brain insulin resistance and upregulating NRF2/HO-1 pathway.

Authors:  Hongyan Li; Tingting Qin; Min Li; Shiping Ma
Journal:  Metab Brain Dis       Date:  2016-10-20       Impact factor: 3.584

6.  Dissociation of muscle insulin sensitivity from exercise endurance in mice by HDAC3 depletion.

Authors:  Sungguan Hong; Wenjun Zhou; Bin Fang; Wenyun Lu; Emanuele Loro; Manashree Damle; Guolian Ding; Jennifer Jager; Sisi Zhang; Yuxiang Zhang; Dan Feng; Qingwei Chu; Brian D Dill; Henrik Molina; Tejvir S Khurana; Joshua D Rabinowitz; Mitchell A Lazar; Zheng Sun
Journal:  Nat Med       Date:  2016-12-19       Impact factor: 53.440

7.  Insulin Receptor Associates with Promoters Genome-wide and Regulates Gene Expression.

Authors:  Melissa L Hancock; Rebecca C Meyer; Meeta Mistry; Radhika S Khetani; Alexandre Wagschal; Taehwan Shin; Shannan J Ho Sui; Anders M Näär; John G Flanagan
Journal:  Cell       Date:  2019-04-04       Impact factor: 41.582

Review 8.  Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training.

Authors:  Ricardo Augusto Leoni De Sousa; Alex Cleber Improta-Caria
Journal:  Metab Brain Dis       Date:  2022-01-25       Impact factor: 3.584

Review 9.  Can functional oligosaccharides reduce the risk of diabetes mellitus?

Authors:  Di Zhu; Qiaojuan Yan; Jun Liu; Xia Wu; Zhengqiang Jiang
Journal:  FASEB J       Date:  2019-08-15       Impact factor: 5.834

10.  Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes.

Authors:  Matthew D Davidson; Kimberly R Ballinger; Salman R Khetani
Journal:  Sci Rep       Date:  2016-06-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.